Blicharski T, Sowa I, Strzemski M, Szwerc W, Majewski A. Inhibition of RANKL a key mediator of osteoclast formation – new opportunities in osteoporosis treatment. Curr. Issues Pharm. Med. Sci. [Internet]. 2025 Apr. 18 [cited 2025 Jun. 8];24(1):179-85. Available from: https://czasopisma.umlub.pl/curipms/article/view/2993